Possibilities of targeted therapy for myelofibrosis: Moscow experience

Background. For many years the primary aim of treatment strategy for ph-negative myeloproliferative neoplasms has been to restrain disease progression, with lasting relief and management of symptoms to improve patients’ quality of life. Generally, this did not lead to a significant increase in life...

Full description

Bibliographic Details
Main Authors: O. Yu. Vinogradova, M. M. Pankrashkina, D. I. Shikhbabaeva, M. V. Chernikov, A. L. Neverova, V. L. Ivanova, E. A. Nikitin, E. V. Usikova, V. V. Ptushkin
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/593